NEW YORK, Sept 21 – The US National Cancer Institute (NCI) has purchased Nanogen’s (Nasdaq: NGEN) NanoChip system for use in cancer research and diagnosis, Nanogen said Thursday.

“The NanoChip system may accelerate this process, allowing us to potentially use this same tool in both the research process and in the patient care process,” Stephen Chanock of the NCI’s Pediatric Oncology Branch at the Advanced Technology Center said in a statement.

Terms of the deal were not disclosed. Representatives of NCI and Nanogen could not immediately be reached for comment.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.